Internal Medicine, Gastroenterology · Elmira, NY
NPI
1356450381
Since 2006
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
555 Saint Josephs Blvd Ste M2
Elmira, NY, 14901
Phone (607) 734-7121
Groups this clinician bills Medicare through
Medicare paid, 2024
$68K
1,034 services
Medicare patients, 2024
449
Average age 73
Drug cost, 2024
$2.8M
2,280 prescriptions
Company payments, 2025
$3,982
From 20 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Bruno R Mazza was code 99214 (office e&m - established), 255 times for 156 patients. In total Bruno R Mazza billed 1,034 services in 22 codes, and Medicare paid $68K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-11-25.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 255 | 156 | $67.00 | $17K |
| 99213 Office E&M - Established | Facility | 235 | 196 | $42.41 | $9,966 |
| G0500 Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | Facility | 210 | 196 | $4.00 | $841 |
| 45385 Colonoscopy - Lesion Removal | Facility | 106 | 105 | $195.21 | $21K |
| 43239 Upper GI Endoscopy | Facility | 55 | 54 | $83.04 | $4,567 |
| 43235 Upper GI Endoscopy | Facility | 40 | 40 | $75.18 | $3,007 |
| G0105 Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 27 | 26 | $158.52 | $4,280 |
| 45380 Lower GI Endoscopy - Other | Facility | 16 | 16 | $88.85 | $1,422 |
| 45378 Lower GI Endoscopy - Other | Facility | 15 | 15 | $120.82 | $1,812 |
| 43450 Digestive/Gastrointestinal | Facility | 14 | 14 | $29.80 | $417 |
| 91200 Standard X-ray | Facility | 12 | 12 | $7.92 | $95.04 |
By year: 2022 $81K for 1,123 services; 2023 $80K for 1,146 services; 2024 $68K for 1,034 services.
Medicare prescription drug claims, 2024
In 2024, the drug Bruno R Mazza prescribed most often to Medicare patients was Pantoprazole Sodium, with 469 prescriptions and refills. In total Bruno R Mazza wrote 2,280 Medicare prescriptions that cost $2.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Pantoprazole Sodium Generic | 469 | 1,070 | 135 | $6,195 |
| Omeprazole Generic | 259 | 466 | 66 | $3,622 |
| Motegrity Prucalopride Succinate | 163 | 277 | 41 | $140K |
| Mesalamine Generic | 83 | 144 | 16 | $50K |
| Xifaxan Rifaximin | 80 | 86 | 22 | $255K |
| Mesalamine Er Mesalamine | 79 | 141 | 15 | $28K |
| Dicyclomine Hcl Generic | 74 | 130 | 21 | $1,969 |
| Linzess Linaclotide | 70 | 108 | 15 | $57K |
| Ursodiol Generic | 67 | 143 | 16 | $13K |
| Famotidine Generic | 67 | 144 | 18 | $749 |
| Clenpiq Sod Picosulf/Mag Ox/Citric Ac | 66 | 66 | 66 | $11K |
| Sucralfate Generic | 63 | 105 | 16 | $8,424 |
| Lansoprazole Generic | 51 | 98 | Under 11 | $1,802 |
| Voquezna Vonoprazan Fumarate | 48 | 50 | 15 | $31K |
| Dexlansoprazole Dr Dexlansoprazole | 45 | 87 | 12 | $12K |
Brand drugs: - claims; generic drugs: 1,535 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Bruno R Mazza $3,982 ($3,982 in general payments such as food, travel and fees) from 20 companies. The largest payer was Abbvie Inc. with $648.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 34 | $648 |
| Janssen Biotech, Inc. JNJ | 57 | $617 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 22 | $473 |
| Madrigal Pharmaceuticals MDGL | 12 | $385 |
| Ardelyx, Inc. ARDX | 11 | $325 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 18 | $289 |
| Regeneron Healthcare Solutions, Inc. REGN | 10 | $277 |
| Exact Sciences Corporation EXAS | 6 | $224 |
| Phathom Pharmaceuticals, Inc. PHAT | 12 | $162 |
| Genzyme Corporation SNY | 6 | $145 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.